Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
NEW YORK (Reuters Health) – Thiazolidinediones (TZDs) are linked to an increased risk for extremity fractures in women over age 65, findings from a large retrospective cohort study…
NEW YORK (Reuters Health) – In patients with coronary shock and multivessel coronary disease, 30-day and 1-year mortality rates appear to be similar after percutaneous coronary intervention (PCI)…
NEW YORK (Reuters Health) – Cladribine and fingolimod, the first oral agents for multiple sclerosis (MS), significantly reduce relapse rates, risks of disability progression, and disease activity, according…
NEW YORK (Reuters Health) – In patients with poor-grade subarachnoid hemorrhage, hypertonic saline improves cerebral blood flow and enhances cerebral tissue oxygenation for 4 hours post-infusion, UK researchers…
NEW YORK (Reuters Health) – In an update to their 2005 recommendation, the US Preventive Services Task Force now recommends that clinicians screen children and adolescents ages 6…
NEW YORK (Reuters Health) – When it comes to preventing atrial fibrillation, not all antihypertensive agents are created equal. New research suggests that angiotensin-converting enzyme (ACE) inhibitors, angiotensin…
NEW YORK (Reuters Health) – Repeat cardiac catheterizations and use of vascular closure devices do not reduce femoral artery size at the puncture site or promote progression of…
NEW YORK (Reuters Health) – Using CT angiography to determine plaque characteristics before electively implanting a coronary artery stent may help gauge the risk of injury or myocardial…
NEW YORK (Reuters Health) – Clinical prediction rules for judging the likelihood of a pulmonary embolism (PE) could be improved, new research shows. Now the rules leave out…
NEW YORK (Reuters Health) – In patients undergoing percutaneous coronary intervention (PCI) for non-ST-segment elevation myocardial infarction, delaying clopidogrel loading until just before or after PCI does not…
